Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × Lacteol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1 Solid Tumor, Adult 1 Papillomavirus Infections 1 Dysbiosis 1 Colorectal Neoplasms 1 Candidiasis, Oral 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 38 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 30 Papillomavirus Vaccines 24 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Data Collection 9 Colposcopy 9 Blood Specimen Collection 9 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Human Papillomavirus DNA Tests 7 Cisplatin 7 Carboplatin 6 Vaginal Smears 5 Vaccines, Synthetic 5 Educational Status 5 Early Intervention, Educational 5 Surveys and Questionnaires 4 Methods 4 Engerix-B 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Polymerase Chain Reaction 3 Paclitaxel 3 Observation 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06467942 2024-06-21

ELIMVLHPV

Peking University People's Hospital

Phase NA Recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡